Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials.
Nicolò E, Gandini S, Giugliano F, Uliano J, D'Ecclesiis O, Morganti S, Ferraro E, Trapani D, Tarantino P, Zagami P, Boldrini L, Caramella I, Carnevale Schianca A, Cristofanilli M, Locatelli MA, Esposito A, Belli C, Minchella I, Criscitiello C, Marra A, Curigliano G. Nicolò E, et al. Among authors: locatelli ma. Eur J Cancer. 2024 Aug;207:114181. doi: 10.1016/j.ejca.2024.114181. Epub 2024 Jun 17. Eur J Cancer. 2024. PMID: 38909537
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility.
Antonarelli G, Taurelli Salimbeni B, Marra A, Esposito A, Locatelli MA, Trapani D, Pescia C, Fusco N, Curigliano G, Criscitiello C. Antonarelli G, et al. Among authors: locatelli ma. Crit Rev Oncol Hematol. 2023 Dec;192:104148. doi: 10.1016/j.critrevonc.2023.104148. Epub 2023 Oct 1. Crit Rev Oncol Hematol. 2023. PMID: 37783318 Review.
Assessment of the Impact of Potential Tetracycline Exposure on the Phenotype of Aedes aegypti OX513A: Implications for Field Use.
Curtis Z, Matzen K, Neira Oviedo M, Nimmo D, Gray P, Winskill P, Locatelli MA, Jardim WF, Warner S, Alphey L, Beech C. Curtis Z, et al. Among authors: locatelli ma. PLoS Negl Trop Dis. 2015 Aug 13;9(8):e0003999. doi: 10.1371/journal.pntd.0003999. eCollection 2015 Aug. PLoS Negl Trop Dis. 2015. PMID: 26270533 Free PMC article.
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.
Curigliano G, Bagnardi V, Bertolini F, Alcalay M, Locatelli MA, Fumagalli L, Rabascio C, Calleri A, Adamoli L, Criscitiello C, Viale G, Goldhirsch A. Curigliano G, et al. Among authors: locatelli ma. Breast. 2015 Jun;24(3):263-71. doi: 10.1016/j.breast.2015.02.036. Epub 2015 Mar 12. Breast. 2015. PMID: 25772326 Clinical Trial.
Dendritic cell-based vaccines: clinical applications in breast cancer.
Gelao L, Criscitiello C, Esposito A, De Laurentiis M, Fumagalli L, Locatelli MA, Minchella I, Santangelo M, De Placido S, Goldhirsch A, Curigliano G. Gelao L, et al. Among authors: locatelli ma. Immunotherapy. 2014;6(3):349-60. doi: 10.2217/imt.13.169. Immunotherapy. 2014. PMID: 24762078 Review.
Locoregional recurrence in patients with HER2 positive breast cancer.
Brollo J, Kneubil MC, Botteri E, Rotmensz N, Duso BA, Fumagalli L, Locatelli MA, Criscitiello C, Lohsiriwat V, Goldhirsch A, Leonardi MC, Orecchia R, Curigliano G. Brollo J, et al. Among authors: locatelli ma. Breast. 2013 Oct;22(5):856-62. doi: 10.1016/j.breast.2013.03.010. Epub 2013 May 1. Breast. 2013. PMID: 23642529